Literature DB >> 10438910

Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction.

S Mukhopadhyay1, A George, V Bal, B Ravindran, S Rath.   

Abstract

We show that macrophages of X-linked immunodeficient mice with a mutant nonfunctional Bruton's tyrosine kinase produce less NO than wild-type macrophages in response to a variety of stimuli. Induction of the inducible NO synthase (iNOS) protein, the transcription factor IFN regulatory factor-1 involved in iNOS expression, and the transcription factor STAT-1 involved in regulating IFN regulatory factor-1 induction are all poorer in X-linked immunodeficient than in wild-type macrophages. On the other hand, induction of IL-12 is higher in X-linked immunodeficient than in wild-type macrophages. Macrophage IL-12 induction is enhanced by iNOS inhibitors such as aminoguanidine and thiocitrulline and is inhibited by NO generation via sodium nitroprusside. There is relative enhancement of IFN-gamma production by immune T cells from mice immunized under aminoguanidine cover. Our data thus suggest that Bruton's tyrosine kinase participates in signaling for iNOS induction via IFN regulatory factor-1 in macrophages and that NO is an inhibitor of IL-12 induction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438910

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Dendritic cell targeted vaccines: Recent progresses and challenges.

Authors:  Pengfei Chen; Xinsheng Liu; Yuefeng Sun; Peng Zhou; Yonglu Wang; Yongguang Zhang
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

2.  Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function.

Authors:  Li Ren; Amanda Campbell; Huiqing Fang; Shalini Gautam; Saranya Elavazhagan; Kavin Fatehchand; Payal Mehta; Andrew Stiff; Brenda F Reader; Xiaokui Mo; John C Byrd; William E Carson; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

3.  Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor.

Authors:  Sheikh Showkat Rahim; Nooruddin Khan; Chandra Sekhar Boddupalli; Seyed E Hasnain; Sangita Mukhopadhyay
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

4.  Inducible nitric oxide synthase is a major intermediate in signaling pathways for the survival of plasma cells.

Authors:  Ankur S Saini; Gautam N Shenoy; Satyajit Rath; Vineeta Bal; Anna George
Journal:  Nat Immunol       Date:  2014-01-19       Impact factor: 25.606

5.  Recombinant Brugia malayi pepsin inhibitor (rBm33) induced monocyte function and absence of apoptotic cell death: an in vitro study.

Authors:  Kirthika Sreenivas; Kamalakannan Vijayan; Subash Babu; Rangarajan Badri Narayanan
Journal:  Microb Pathog       Date:  2012-03-30       Impact factor: 3.738

Review 6.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

7.  Inducible nitric oxide synthase in T cells regulates T cell death and immune memory.

Authors:  Monika Vig; Smita Srivastava; Usha Kandpal; Hadassah Sade; Virginia Lewis; Apurva Sarin; Anna George; Vineeta Bal; Jeannine M Durdik; Satyajit Rath
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  Ibrutinib enhances IL-17 response by modulating the function of bone marrow derived dendritic cells.

Authors:  Gayathri Natarajan; Cesar Terrazas; Steve Oghumu; Sanjay Varikuti; Jason A Dubovsky; John C Byrd; Abhay R Satoskar
Journal:  Oncoimmunology       Date:  2015-06-09       Impact factor: 8.110

9.  Bruton's tyrosine kinase defect in dendritic cells from X-linked agammaglobulinaemia patients does not influence their differentiation, maturation and antigen-presenting cell function.

Authors:  M C Gagliardi; A Finocchi; P Orlandi; L Cursi; C Cancrini; V Moschese; T Miyawaki; P Rossi
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

Review 10.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.